TipRanks
Beijing Biostar Pharmaceuticals Co., Ltd. Class H (HK:2563)
:2563
Hong Kong Market
2563
Beijing Biostar Pharmaceuticals Co., Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:2563 full AI Analyst Report?

Beijing Biostar Pharmaceuticals Co., Ltd. Class H (2563) Ratios

0 Followers

Beijing Biostar Pharmaceuticals Co., Ltd. Class H Ratios

HK:2563's free cash flow for Q2 2026 was HK$0.93. For the 2026 fiscal year, HK:2563's free cash flow was decreased by HK$ and operating cash flow was HK$-0.54. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Jun 25Dec 23Dec 22
Liquidity Ratios
Current Ratio
 8.77 8.33 8.83 14.48 15.56
Quick Ratio
 8.00 7.67 8.44 13.86 14.96
Cash Ratio
 7.13 6.58 5.89 0.87 1.16
Solvency Ratio
 -0.96 -1.09 -1.11 -3.67 -2.59
Operating Cash Flow Ratio
 -0.88 -2.18 -1.42 -3.45 -1.54
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
HK$ 518.13MHK$ 522.70MHK$ 613.56MHK$ 646.76MHK$ 849.92M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.16 1.16 1.15 1.07 1.07
Debt Service Coverage Ratio
 0.00 -1.36K -1.46K -4.00K -2.95K
Interest Coverage Ratio
 0.00 -1.47K -1.55K -4.20K -2.56K
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 4.88 3.62 2.85 0.21 0.39
Profitability Margins
Gross Profit Margin
92.47%90.66%80.20%70.27%72.76%
EBIT Margin
-182.79%-407.86%-236.63%-324.87%-591.81%
EBITDA Margin
-163.43%-376.56%-222.98%-311.10%-564.10%
Operating Profit Margin
-195.39%-407.86%-236.63%-326.74%-488.85%
Pretax Profit Margin
-192.97%-384.03%-200.06%-284.60%-489.06%
Net Profit Margin
-192.97%-384.03%-200.06%-284.60%-489.06%
Continuous Operations Profit Margin
-192.97%-384.03%-200.06%-284.60%-489.06%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
98.76%94.16%84.55%87.10%100.04%
Return on Assets (ROA)
-14.56%-16.55%-16.05%-24.55%-17.33%
Return on Equity (ROE)
-16.60%-19.24%-18.53%-26.22%-18.49%
Return on Capital Employed (ROCE)
-16.10%-19.31%-20.78%-29.92%-22.88%
Return on Invested Capital (ROIC)
-16.09%-19.28%-20.76%-29.89%-22.85%
Return on Tangible Assets
-14.80%-16.82%-16.28%-24.61%-17.38%
Earnings Yield
-7.95%-7.98%-2.17%-2.77%-2.41%
Efficiency Ratios
Receivables Turnover
 2.68 0.51 3.05 5.97 0.95
Payables Turnover
 0.08 0.05 0.30 0.81 0.44
Inventory Turnover
 0.09 0.06 0.46 0.73 0.29
Fixed Asset Turnover
 0.39 0.23 0.44 0.49 0.28
Asset Turnover
 0.08 0.04 0.08 0.09 0.04
Working Capital Turnover Ratio
 0.12 0.06 0.12 0.10 0.04
Cash Conversion Cycle
 -245.98 -443.87 -306.04 115.93 839.54
Days of Sales Outstanding
 136.06 722.27 119.62 63.84 390.02
Days of Inventory Outstanding
 4.16K 6.37K 790.80 502.40 1.27K
Days of Payables Outstanding
 4.55K 7.54K 1.22K 450.31 820.60
Operating Cycle
 4.30K 7.09K 910.42 566.24 1.66K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.17 -0.46 -0.33 -0.47 -0.26
Free Cash Flow Per Share
 -0.18 -0.48 -0.45 -0.56 -0.36
CapEx Per Share
 <0.01 0.02 0.12 0.09 0.10
Free Cash Flow to Operating Cash Flow
 1.05 1.04 1.36 1.18 1.40
Dividend Paid and CapEx Coverage Ratio
 -18.54 -27.72 -2.76 -5.42 -2.49
Capital Expenditure Coverage Ratio
 -18.54 -27.96 -2.76 -5.42 -2.49
Operating Cash Flow Coverage Ratio
 -39.46 -76.72 -95.27 -167.72 -41.72
Operating Cash Flow to Sales Ratio
 -0.99 -4.54 -1.54 -2.26 -2.42
Free Cash Flow Yield
-6.45%-9.78%-2.27%-2.61%-1.68%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -12.51 -12.54 -46.07 -31.62 -35.28
Price-to-Sales (P/S) Ratio
 16.10 48.10 92.18 89.98 172.54
Price-to-Book (P/B) Ratio
 2.12 2.41 8.54 8.29 6.52
Price-to-Free Cash Flow (P/FCF) Ratio
 -15.50 -10.23 -44.02 -33.57 -50.88
Price-to-Operating Cash Flow Ratio
 -24.64 -10.59 -59.97 -39.77 -71.29
Price-to-Earnings Growth (PEG) Ratio
 -0.61 1.35 1.78 -2.06 0.76
Enterprise Value Multiple
 -4.97 -9.15 -38.49 -28.74 -30.27
Enterprise Value
 524.79M 1.28B 6.69B 7.54B 7.52B
EV to EBITDA
 -4.97 -9.15 -38.49 -38.08 -44.02
EV to Sales
 8.13 34.47 85.82 102.27 201.11
EV to Free Cash Flow
 -7.83 -7.33 -40.98 -38.15 -58.87
EV to Operating Cash Flow
 -8.25 -7.59 -55.83 -45.20 -83.09
Tangible Book Value Per Share
 1.99 1.99 2.27 2.27 2.81
Shareholders’ Equity Per Share
 2.03 2.03 2.31 2.27 2.82
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.18 0.10 0.21 0.21 0.11
Net Income Per Share
 -0.34 -0.39 -0.43 -0.60 -0.52
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.06 0.94 0.85 1.00 1.00
Research & Development to Revenue
 1.12 2.49 1.59 1.90 1.88
SG&A to Revenue
 1.51 1.15 0.57 2.09 3.11
Stock-Based Compensation to Revenue
 -0.02 0.00 0.12 0.67 2.46
Income Quality
 0.51 1.15 0.78 0.80 0.49
Currency in HKD